ABSTRACT Objective: To compare the efficacy and safety of the iStent inject® and iStent inject® W in patients with primary open-angle glaucoma (POAG) undergoing standalone or combined implantation with phacoemulsification. Methods: Retrospective longitudinal study including 103 eyes with mild-to-moderate POAG. Intraocular pressure (IOP), number of medications, absolute and relative success rates, survival analysis, and safety outcomes were evaluated over 12 months. Results: Fifty-nine eyes received iStent inject® (Group 1) and 44 received iStent inject® W (Group 2). Mean IOP decreased […]

ABSTRACT Our objective was to report the case of the use of Xen® Gel Stent in the surgical treatment of glaucoma secondary to iridocorneal endothelial syndrome. Female patient, 38 years old, with unilateral glaucoma secondary to iridocorneal endothelial syndrome in the right eye, using maximum tolerable medications (three medications), with medicated intraocular pressure oscillating between 16 and 18 mmHg, demonstrating structural and functional progression, underwent minimally invasive bleb surgery with ab interno closed-conjunctival implantation of a Xen® Gel Stent. The […]